The Alien franchise works because it traps its characters in impossible situations where survival depends on cunning, luck, ...

New research shows it's possible to reprogram skin cells into eggs that can be fertilized in the lab, though it's just a ...

These injected mitochondria change the overall complex of genes expressed in the recipient cells. They also induce the ...

Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.

Trinity College Dublin scientists showed that electrical stimulation reprograms macrophages to reduce inflammation and boost healing. This breakthrough could lead to broad therapeutic uses.

Preclinical experiments and an ongoing phase 1 trial suggest that RES-010 may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists.

Details of a new drug that aims to treat the underlying causes of obesity were presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 ...

In a Cambridge lab, a team of scientists may have found a new way to fight the most aggressive brain cancer—not by killing it, but by locking it in place. Glioblastoma, the deadliest and most common ...

If you own a smart TV, then you probably have streamer buttons on your remote control. This handy feature allows you to easily jump from an app like Netflix to Disney+, without having to escape back ...

Ken McElroy explores how to reprogram your thoughts for success, shifting from scarcity to abundance. Discover practical steps to achieve financial freedom through mindset. Massive Donald Trump and ...

Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding off-target effects, immune activation, and unnecessary drug exposure. (Nanowerk ...

Data Supports the Nomination of OTX-201, a Novel In Vivo CAR-T Therapy, as Orbital’s First Product Candidate Company Plans to Advance OTX-201 Toward Clinical Development for B Cell-Driven Autoimmune ...